ATLANTA, Nov. 8, 2023
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading
cardiac and vascular surgery company focused on aortic disease,
today announced that it will participate in two upcoming investor
conferences.
Artivion's management team will present at the
upcoming Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at the Lotte New
York Palace. The Company's presentation is scheduled to begin at
9:45a.m. ET. A live webcast can be
accessed through Artivion's website, www.artivion.com, on the
Investors page. An archived copy of the webcast will be available
for 90 days on the same website.
Members of the management team will also host one-on-one
meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and
Digital Health & Services Forum on Thursday, November 16, 2023. Due to the format of
this event no webcast will be available.
About Artivion, Inc.
Headquartered in suburban
Atlanta, Georgia, Artivion, Inc.
is a medical device company focused on developing simple, elegant
solutions that address cardiac and vascular surgeons' most
difficult challenges in treating patients with aortic diseases.
Artivion's four major groups of products include: aortic stent
grafts, surgical sealants, On-X mechanical heart valves, and
implantable cardiac and vascular human tissues. Artivion markets
and sells products in more than 100 countries worldwide. For
additional information about Artivion, visit our website,
www.artivion.com.
|
Contacts:
|
|
|
Artivion
|
Gilmartin Group
LLC
|
|
D. Ashley
Lee
|
Brian Johnston / Lynn
Lewis
|
|
Executive Vice
President &
|
Phone:
332-895-3222
|
|
Chief Financial
Officer
|
investors@artivion.com
|
|
Phone:
770-419-3355
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-301982323.html
SOURCE Artivion, Inc.
